News Releases
NOTICE TO HOSPITALS HEALTH CANADA ENDORSED IMPORTANT SAFETY INFORMATION ON YERVOY 200 MG/40 ML(5 MG/ML) (IPILIMUMAB FOR INJECTION), SINGLE-USE VIAL
Subject: Recall of YERVOY (ipilimumab for injection) 200 mg/40 mL vial DIN 02379384 – Lots 924741 and 924041
Yervoy
18/10/14
Dear Healthcare Professional:
Please distribute to relevant Departments of Pharmacy, Oncology, Oncology clinics, Internal Medicine, Nursing, and other Departments as required, and other involved professional staff and post this notice in your institution.